Fig. 3.
Sustained release of drugs from nanofibrous membranes in vitro. (a) Cumulative release rate of naringenin and vitamin K2; (b) The structural formula of naringenin; (c) The structural formula of vitamin K2.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.